Meptin Inhalation Solution Overdosage

Administrations of Meptin Inhalation Solution to patients in excess of the recommended doses can cause ventricular arrhythmias (ventricular tachycardia, ventricular fibrillation and other symptoms), cardiac arrest, and other severe adverse reactions. Patients should be properly instructed on the dose and method of administration of Meptin Inhalation Solution (see Dosage & Administration and Precautions).
Overdosage with Meptin Inhalation Solution has been associated with tachycardia, tachycardiac arrhythmia, hypotension, nervousness, tremor, hypokalemia and hyperglycemia.
In the event any overdosage-related abnormalities are observed, Meptin Inhalation Solution should be discontinued and if required, gastric lavage should be performed to remove any unabsorbed drug. Emergency treatment and general maintenancy therapy should also be provided if needed.
In the event serious tachycardiac arrhythmia has developed, β-blockers eg, propranolol may be effective but administration of these drugs to asthma patients should be performed with care because β-blockers may increase airway resistance in these patients.